-
1
-
-
0023191317
-
Fibromyalgia
-
Bennett RM. Fibromyalgia. JAMA. 1987;257:2802-2803.
-
(1987)
JAMA
, vol.257
, pp. 2802-2803
-
-
Bennett, R.M.1
-
3
-
-
84856599951
-
Fibromyalgia: mechanisms and potential impact of the ACR 2010 classification criteria
-
McBeth J, Mulvey MR. Fibromyalgia: mechanisms and potential impact of the ACR 2010 classification criteria. Nat Rev Rheumatol. 2012;8:108-116.
-
(2012)
Nat Rev Rheumatol
, vol.8
, pp. 108-116
-
-
McBeth, J.1
Mulvey, M.R.2
-
4
-
-
80053129151
-
Fibromyalgia diagnosis and diagnostic criteria
-
Wolfe F, Hauser W. Fibromyalgia diagnosis and diagnostic criteria. Ann Med. 2011;43:495-502.
-
(2011)
Ann Med
, vol.43
, pp. 495-502
-
-
Wolfe, F.1
Hauser, W.2
-
5
-
-
80051771019
-
Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia
-
Sun P, Zhao Y, Zhao Z, Watson P. Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia. Curr Med Res Opin. 2011;27:1793-801.
-
(2011)
Curr Med Res Opin
, vol.27
, pp. 1793-1801
-
-
Sun, P.1
Zhao, Y.2
Zhao, Z.3
Watson, P.4
-
6
-
-
79955588326
-
Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia
-
Zhao Y, Sun P, Watson P, Mitchell B, Swindle R. Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia. Pain Pract. 2011;11:204-216.
-
(2011)
Pain Pract
, vol.11
, pp. 204-216
-
-
Zhao, Y.1
Sun, P.2
Watson, P.3
Mitchell, B.4
Swindle, R.5
-
7
-
-
77953120247
-
Prevalence of fibromyalgia: a survey in five European countries
-
Branco JC, Bannwarth B, Failde I, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2009; 39: 448-453.
-
(2009)
Semin Arthritis Rheum
, vol.39
, pp. 448-453
-
-
Branco, J.C.1
Bannwarth, B.2
Failde, I.3
-
8
-
-
61449244752
-
Fibromyalgia syndrome in the general population of France: a prevalence study
-
Bannwarth B, Blotman F, Roue-Le Lay K, Caubere JP, Andre E, Taieb C. Fibromyalgia syndrome in the general population of France: a prevalence study. Joint Bone Spine. 2009;76:184-187.
-
(2009)
Joint Bone Spine
, vol.76
, pp. 184-187
-
-
Bannwarth, B.1
Blotman, F.2
Roue-Le Lay, K.3
Caubere, J.P.4
Andre, E.5
Taieb, C.6
-
9
-
-
52649170911
-
Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain
-
Mas AJ, Carmona L, Valverde M, Ribas B. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clin Exp Rheumatol. 2008;26:519-526.
-
(2008)
Clin Exp Rheumatol
, vol.26
, pp. 519-526
-
-
Mas, A.J.1
Carmona, L.2
Valverde, M.3
Ribas, B.4
-
10
-
-
34247494827
-
The prevalence of fibromyalgia in Japanese workers
-
Toda K. The prevalence of fibromyalgia in Japanese workers. Scand J Rheumatol. 2007;36:140-144.
-
(2007)
Scand J Rheumatol
, vol.36
, pp. 140-144
-
-
Toda, K.1
-
11
-
-
0041570006
-
Elements of fibromyalgia in an open population
-
Schochat T, Raspe H. Elements of fibromyalgia in an open population. Rheumatology (Oxford). 2003;42:829-835.
-
(2003)
Rheumatology (Oxford)
, vol.42
, pp. 829-835
-
-
Schochat, T.1
Raspe, H.2
-
12
-
-
0030608662
-
Prevalence of chronic fatigue syndrome and primary fibromyalgia syndrome in The Netherlands
-
Bazelmans E, Vercoulen JH, Galama JM, van Weel C, van der Meer JW, Bleijenberg G. Prevalence of chronic fatigue syndrome and primary fibromyalgia syndrome in The Netherlands. Ned Tijdschr Geneeskd. 1997;141:1520-1523.
-
(1997)
Ned Tijdschr Geneeskd
, vol.141
, pp. 1520-1523
-
-
Bazelmans, E.1
Vercoulen, J.H.2
Galama, J.M.3
van Weel, C.4
van der Meer, J.W.5
Bleijenberg, G.6
-
13
-
-
0029763121
-
The prevalence and meaning of fatigue in rheumatic disease
-
Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol. 1996;23:1407-1417.
-
(1996)
J Rheumatol
, vol.23
, pp. 1407-1417
-
-
Wolfe, F.1
Hawley, D.J.2
Wilson, K.3
-
14
-
-
0030342690
-
Epidemiological study of a primary fibromyalgia in pediatric age
-
Sardini S, Ghirardini M, Betelemme L, Arpino C, Fatti F, Zanini F. Epidemiological study of a primary fibromyalgia in pediatric age. Minerva Pediatr. 1996;48:543-550.
-
(1996)
Minerva Pediatr
, vol.48
, pp. 543-550
-
-
Sardini, S.1
Ghirardini, M.2
Betelemme, L.3
Arpino, C.4
Fatti, F.5
Zanini, F.6
-
15
-
-
0028890678
-
The prevalence and characteristics of fibromyalgia in the general population
-
Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19-28.
-
(1995)
Arthritis Rheum
, vol.38
, pp. 19-28
-
-
Wolfe, F.1
Ross, K.2
Anderson, J.3
Russell, I.J.4
Hebert, L.5
-
16
-
-
0028906176
-
Fibromyalgia syndrome in children-an outcome study
-
Buskila D, Neumann L, Hershman E, Gedalia A, Press J, Sukenik S. Fibromyalgia syndrome in children-an outcome study. J Rheumatol. 1995;22:525-528.
-
(1995)
J Rheumatol
, vol.22
, pp. 525-528
-
-
Buskila, D.1
Neumann, L.2
Hershman, E.3
Gedalia, A.4
Press, J.5
Sukenik, S.6
-
17
-
-
85030492604
-
-
NFA. Prevalence of Fibromyalgia. (accessed May 5, 2009).
-
NFA. Prevalence of Fibromyalgia. 2009. http://www.fmaware.org/site/PageServer?pagename=fibromyalgia_affected (accessed May 5, 2009).
-
(2009)
-
-
-
18
-
-
85030495707
-
-
WD. Prevalence and Incidence of Fibromyalgia. (accessed May 5, 2009).
-
WD. Prevalence and Incidence of Fibromyalgia. 2009. http://www.wrongdiagnosis.com/f/fibromyalgia/stats.htm (accessed May 5, 2009).
-
(2009)
-
-
-
19
-
-
84891623709
-
-
NIAMS. Fibromyalgia. (accessed May 5, 2009).
-
NIAMS. Fibromyalgia. 1999. http://www.niams.nih.gov/Health_Info/Fibromyalgia/default.asp (accessed May 5, 2009).
-
(1999)
-
-
-
20
-
-
41849093775
-
EULAR evidence-based recommendations for the management of fibromyalgia syndrome
-
Carville SF, Arendt-Nielsen S, Bliddal H, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008;67:536-541.
-
(2008)
Ann Rheum Dis
, vol.67
, pp. 536-541
-
-
Carville, S.F.1
Arendt-Nielsen, S.2
Bliddal, H.3
-
22
-
-
64249124632
-
Fibromyalgia: presentation and management with a focus on pharmacological treatment
-
Sumpton JE, Moulin DE. Fibromyalgia: presentation and management with a focus on pharmacological treatment. Pain Res Manag. 2008;13:477-483.
-
(2008)
Pain Res Manag
, vol.13
, pp. 477-483
-
-
Sumpton, J.E.1
Moulin, D.E.2
-
23
-
-
33745588681
-
Guideline for the management of fibromyalgia syndrome pain in adults and children
-
Glenview, IL: American Pain Society (APS); 2005. 109 p. Clinical practice guideline; no. 4.
-
Buckhardt CS, Goldenberg D, Crofford L, et al. Guideline for the management of fibromyalgia syndrome pain in adults and children. Glenview, IL: American Pain Society (APS); 2005. 109 p. Clinical practice guideline; no. 4.
-
-
-
Buckhardt, C.S.1
Goldenberg, D.2
Crofford, L.3
-
24
-
-
72049123263
-
Guidelines on the management of fibromyalgia syndrome-a systematic review
-
Hauser W, Thieme K, Turk DC. Guidelines on the management of fibromyalgia syndrome-a systematic review. Eur J Pain. 2009;14:5-10.
-
(2009)
Eur J Pain
, vol.14
, pp. 5-10
-
-
Hauser, W.1
Thieme, K.2
Turk, D.C.3
-
25
-
-
0036196878
-
Management of fibromyalgia: what are the best treatment choices?
-
Forseth KK, Gran JT. Management of fibromyalgia: what are the best treatment choices? Drugs. 2002;62:577-592.
-
(2002)
Drugs.
, vol.62
, pp. 577-592
-
-
Forseth, K.K.1
Gran, J.T.2
-
26
-
-
46249108179
-
Ottawa Panel evidence-based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1
-
Brosseau L, Wells GA, Tugwell P, et al. Ottawa Panel evidence-based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Phys Ther. 2008;88:857-871.
-
(2008)
Phys Ther
, vol.88
, pp. 857-871
-
-
Brosseau, L.1
Wells, G.A.2
Tugwell, P.3
-
27
-
-
46249100866
-
Ottawa panel evidence-based clinical practice guidelines for strengthening exercises in the management of fibromyalgia: part 2
-
Brosseau L, Wells GA, Tugwell P, et al. Ottawa panel evidence-based clinical practice guidelines for strengthening exercises in the management of fibromyalgia: part 2. Phys Ther. 2008;88:873-886.
-
(2008)
Phys Ther
, vol.88
, pp. 873-886
-
-
Brosseau, L.1
Wells, G.A.2
Tugwell, P.3
-
28
-
-
41649090384
-
Pain management in fibromyalgia
-
Crofford LJ. Pain management in fibromyalgia. Curr Opin Rheumatol. 2008;20:246-250.
-
(2008)
Curr Opin Rheumatol
, vol.20
, pp. 246-250
-
-
Crofford, L.J.1
-
29
-
-
67449142554
-
Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial
-
Garcia-Campayo J, Serrano-Blanco A, Rodero B, et al. Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial. Trials. 2009;10:24.
-
(2009)
Trials
, vol.10
, pp. 24
-
-
Garcia-Campayo, J.1
Serrano-Blanco, A.2
Rodero, B.3
-
30
-
-
43549091316
-
Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial
-
Russell IJ, Mease PJ, Smith TR, et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain. 2008;136:432-444.
-
(2008)
Pain
, vol.136
, pp. 432-444
-
-
Russell, I.J.1
Mease, P.J.2
Smith, T.R.3
-
31
-
-
40649095921
-
A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia
-
Mease PJ, Russell IJ, Arnold LM, et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol. 2008;35:502-514.
-
(2008)
J Rheumatol
, vol.35
, pp. 502-514
-
-
Mease, P.J.1
Russell, I.J.2
Arnold, L.M.3
-
32
-
-
43549104210
-
Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin
-
Crofford LJ, Mease PJ, Simpson SL, et al. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain. 2008;136:419-431.
-
(2008)
Pain
, vol.136
, pp. 419-431
-
-
Crofford, L.J.1
Mease, P.J.2
Simpson, S.L.3
-
33
-
-
57649234533
-
Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial
-
erratum appears in Clin Ther. 2009 Feb;31(2):446].
-
Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. [erratum appears in Clin Ther. 2009 Feb;31(2):446]. Clin Ther. 2008;30:1988-2004.
-
(2008)
Clin Ther
, vol.30
, pp. 1988-2004
-
-
Clauw, D.J.1
Mease, P.2
Palmer, R.H.3
Gendreau, R.M.4
Wang, Y.5
-
34
-
-
34247857419
-
Pregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: an open-label, prospective trial
-
Calandre EP, Morillas-Arques P, Rodriguez-Lopez CM, Rico-Villademoros F, Hidalgo J. Pregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: an open-label, prospective trial. Pharmacopsychiatry. 2007;40:68-71.
-
(2007)
Pharmacopsychiatry.
, vol.40
, pp. 68-71
-
-
Calandre, E.P.1
Morillas-Arques, P.2
Rodriguez-Lopez, C.M.3
Rico-Villademoros, F.4
Hidalgo, J.5
-
35
-
-
26444518188
-
Efficacy of milnacipran in patients with fibromyalgia
-
Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol. 2005;32:1975-1985.
-
(2005)
J Rheumatol.
, vol.32
, pp. 1975-1985
-
-
Gendreau, R.M.1
Thorn, M.D.2
Gendreau, J.F.3
-
36
-
-
20244389715
-
Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial
-
Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52:1264-1273.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 1264-1273
-
-
Crofford, L.J.1
Rowbotham, M.C.2
Mease, P.J.3
-
37
-
-
28644442626
-
A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder
-
Arnold LM, Rosen A, Pritchett YL, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005;119:5-15.
-
(2005)
Pain.
, vol.119
, pp. 5-15
-
-
Arnold, L.M.1
Rosen, A.2
Pritchett, Y.L.3
-
38
-
-
6344231258
-
A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia
-
Vitton O, Gendreau M, Gendreau J, Kranzler J, Rao SG. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol. 2004;19(Suppl 1):S27-35.
-
(2004)
Hum Psychopharmacol
, vol.19
, Issue.SUPPL. 1
-
-
Vitton, O.1
Gendreau, M.2
Gendreau, J.3
Kranzler, J.4
Rao, S.G.5
-
39
-
-
4444381930
-
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder
-
Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004;50:2974-2984.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 2974-2984
-
-
Arnold, L.M.1
Lu, Y.2
Crofford, L.J.3
-
40
-
-
77951765546
-
Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports
-
Straube S, Derry S, Moore RA, McQuay HJ. Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports. Rheumatology (Oxford). 2010;49:706-715.
-
(2010)
Rheumatology (Oxford)
, vol.49
, pp. 706-715
-
-
Straube, S.1
Derry, S.2
Moore, R.A.3
McQuay, H.J.4
-
41
-
-
77952742362
-
Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome
-
Hauser W, Petzke F, Sommer C. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain. 2010;11:505-521.
-
(2010)
J Pain.
, vol.11
, pp. 505-521
-
-
Hauser, W.1
Petzke, F.2
Sommer, C.3
-
42
-
-
84856058020
-
Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care
-
Gore M, Tai KS, Chandran A, Zlateva G, Leslie D. Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care. J Med Econ. 2012;15:19-31.
-
(2012)
J Med Econ.
, vol.15
, pp. 19-31
-
-
Gore, M.1
Tai, K.S.2
Chandran, A.3
Zlateva, G.4
Leslie, D.5
-
43
-
-
84855727551
-
Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine
-
Burke JP, Sanchez RJ, Joshi AV, Cappelleri JC, Kulakodlu M, Halpern R. Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine. Pain Pract. 2012;12:14-22.
-
(2012)
Pain Pract.
, vol.12
, pp. 14-22
-
-
Burke, J.P.1
Sanchez, R.J.2
Joshi, A.V.3
Cappelleri, J.C.4
Kulakodlu, M.5
Halpern, R.6
-
44
-
-
80655127867
-
Health outcomes and costs among employees with fibromyalgia treated with pregabalin vs. standard of care
-
Kleinman NL, Sanchez RJ, Lynch WD, Cappelleri JC, Beren IA, Joshi AV. Health outcomes and costs among employees with fibromyalgia treated with pregabalin vs. standard of care. Pain Pract. 2011;11:540-551.
-
(2011)
Pain Pract.
, vol.11
, pp. 540-551
-
-
Kleinman, N.L.1
Sanchez, R.J.2
Lynch, W.D.3
Cappelleri, J.C.4
Beren, I.A.5
Joshi, A.V.6
-
45
-
-
79955591100
-
Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine
-
Harnett J, Margolis J, Cao Z, et al. Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine. Pain Pract. 2011;11:217-229.
-
(2011)
Pain Pract.
, vol.11
, pp. 217-229
-
-
Harnett, J.1
Margolis, J.2
Cao, Z.3
-
46
-
-
0026576098
-
Comorbidity of fibromyalgia with medical and psychiatric disorders
-
Hudson JI, Goldenberg DL, Pope HG, et al. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med. 1992;92:363-367.
-
(1992)
Am J Med
, vol.92
, pp. 363-367
-
-
Hudson, J.I.1
Goldenberg, D.L.2
Pope, H.G.3
-
47
-
-
1642485110
-
Comorbidity of fibromyalgia and posttraumatic stress disorder symptoms in a community sample of women
-
Raphael KG, Janal MN, Nayak S. Comorbidity of fibromyalgia and posttraumatic stress disorder symptoms in a community sample of women. Pain Med. 2004;5:33-41.
-
(2004)
Pain Med.
, vol.5
, pp. 33-41
-
-
Raphael, K.G.1
Janal, M.N.2
Nayak, S.3
-
48
-
-
17044380264
-
Psychiatric comorbidity in fibromyalgia
-
Bradley LA. Psychiatric comorbidity in fibromyalgia. Curr Pain Headache Rep. 2005;9:79-86.
-
(2005)
Curr Pain Headache Rep
, vol.9
, pp. 79-86
-
-
Bradley, L.A.1
-
49
-
-
33645749180
-
Is there an association between fibromyalgia and an increase in comorbidity: neoplastic and cardiovascular diseases, infections and mortality?
-
Chamizo-Carmona E. Is there an association between fibromyalgia and an increase in comorbidity: neoplastic and cardiovascular diseases, infections and mortality?. Reumatol Clin. 2005;1:200-210.
-
(2005)
Reumatol Clin.
, vol.1
, pp. 200-210
-
-
Chamizo-Carmona, E.1
-
50
-
-
34848818749
-
Comorbidity of fibromyalgia and psychiatric disorders
-
Buskila D, Cohen H. Comorbidity of fibromyalgia and psychiatric disorders. Curr Pain Headache Rep. 2007;11:333-338.
-
(2007)
Curr Pain Headache Rep
, vol.11
, pp. 333-338
-
-
Buskila, D.1
Cohen, H.2
-
52
-
-
38049152731
-
Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss
-
White LA, Birnbaum HG, Kaltenboeck A, Tang J, Mallett D, Robinson RL. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss. J Occup Environ Med. 2008;50:13-24.
-
(2008)
J Occup Environ Med
, vol.50
, pp. 13-24
-
-
White, L.A.1
Birnbaum, H.G.2
Kaltenboeck, A.3
Tang, J.4
Mallett, D.5
Robinson, R.L.6
-
53
-
-
61849106634
-
Fibromyalgia comorbidity in primary headaches
-
de Tommaso M, Sardaro M, Serpino C, et al. Fibromyalgia comorbidity in primary headaches. Cephalalgia. 2009;29:453-464.
-
(2009)
Cephalalgia
, vol.29
, pp. 453-464
-
-
de Tommaso, M.1
Sardaro, M.2
Serpino, C.3
-
54
-
-
79951820154
-
Fibromyalgia and psychiatric comorbidity: their effect on the quality of life patients
-
Gonzalez E, Elorza J, Failde I. Fibromyalgia and psychiatric comorbidity: their effect on the quality of life patients. Actas Esp Psiquiatr. 2010;38:295-300.
-
(2010)
Actas Esp Psiquiatr.
, vol.38
, pp. 295-300
-
-
Gonzalez, E.1
Elorza, J.2
Failde, I.3
-
55
-
-
80052508348
-
Fibromyalgia symptoms, physical function, and comorbidity in middle-aged and older adults
-
Shillam CR, Dupree Jones K, Miller L. Fibromyalgia symptoms, physical function, and comorbidity in middle-aged and older adults. Nurs Res. 2011;60:309-317.
-
(2011)
Nurs Res
, vol.60
, pp. 309-317
-
-
Shillam, C.R.1
Dupree Jones, K.2
Miller, L.3
-
56
-
-
77951622706
-
The central role of the propensity score in observational studies for causal effects
-
Rosenbaum P, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
-
(1983)
Biometrika
, vol.70
, pp. 41-55
-
-
Rosenbaum, P.1
Rubin, D.2
|